
09.12.2022
the start of the COVID-19 pandemic (January 2019 – February 2020) (n = 30) and those examined during

09.12.2022
to the COVID-19 pandemic: increased epidemic risk of tuberculosis infection sources and increased exposure

09.12.2022
and adolescents in Moscow using two different options according to age; to determine impact of the COVID

08.11.2022
The objective of this review is to optimize the use of antibiotic therapy for COVID-19 based

11.10.2022
diagnosis of lung injury caused by COVID-19 and pneumocystis pneumonia.
The main complaints in COVID

09.09.2022
COVID-19 is a viral infection and its prevalence requires investigation of different co-morbid

09.09.2022
foreign citizens in Novosibirsk Oblast during the COVID-19 pandemic and related restrictive measures

12.08.2022
The objective: to define hemogram parameters in smokers with COVID-19 and acute coronary syndrome

13.07.2022
The objective: to increase efcacy of treatment of patients with new coronavirus infection COVID

09.06.2022
The article describes a clinical case of viral pneumonia associated with COVID-19 of the only lung

09.06.2022
The patient with severe viral-bacterial pneumonia and verified COVID-19 was successfully treated

14.05.2022
TREC and KREC as prognostic markers of HIV infection and COVID-19

14.05.2022
The objective: to study clinical and laboratory specific parameters of the COVID-19 course

14.05.2022
in a patient with severe COVID-19 coronavirus infection and a fatal outcome. The clinical manifestations

06.04.2022
Tuberculosis Situation in the Years of the COVID-19 Pandemic – 2020-2021

06.04.2022
The review considers data from 28 publications devoted to the specific impact of COVID

06.04.2022
and COVID-19. The patient underwent additional examination due to abnormalities on his X-ray. Large volume

14.03.2022
The objective of the study: to investigate diagnostics, course and outcomes of COVID

11.02.2022
The article analyzes 46 publications on the use of ICS for COVID-19. Both research results

11.02.2022
function in patients with pulmonary hypertension and COVID-19.
Subjects: The study included 53 patients